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Antidiuretic hormone (ADH) is clearly the hor-
mone of paramount importance in the regulation of
water excretion by the mammalian kidney. However,
other hormones also influence renal water excretion
and this portion of the symposium will examine how
some of these hormones exert their effects. Because of
the interrelationships of endocrine systems in home-
ostasis, almost any known hormone might be con-
strued as having some effect; however, we shall con-
sider here only those hormones which are thought to
have major effects on renal handling of water. In
theory, these effects might be mediated directly by
hormonal alteration of renal tubular permeability to
water, renal hemodynamics, tubular fluid and plasma
electrolyte concentrations, collecting duct sensitivity
to ADH or tubular fluid delivery to concentrating
and diluting segments of the nephron. As will be
apparent from this review, some hormones are
known to combine several of these actions while the
actions of others remain uncertain.
Catecholamines
The observation by Rydin and Verney [1] that the
decrease in urine flow which occurs during emotional
stress could be reversed by administration of epi-
nephrine led to the suspicion that endogenous cate-
cholamines may play an important role in regulating
renal water excetion. More recently, Smythe, Nickel,
and Bradley [2] and Baldwin, Gambos and Chasis [3]
demonstrated that adrenal medullary hormones in-
creased free water excretion in normal hydropenic
man. This effect occurred in the absences of changes
in osmolar clearance, renal plasma flow or filtration
fraction, but was associated with an increase in arte-
rial pressure.
Subsequent observations derived from the dog [4],
rat [5] and man [6] have shown that catecholamines,
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such as norepinephrine, which are predominantly al-
pha-adrenergic agonist, cause a diuresis. Conversely,
isoproterenol, a beta-adrenergic agonist, causes an
antidiuresis in the same species [7-9]. The mecha-
nisms by which the alpha- and beta-adrenergic agon-
ists exert these effects on water excretion have been
the object of a great deal of investigation.
In vitro studies in the toad bladder have indicated
that the adrenergic agents alone do not alter water
permeability of the membrane, but that these hor-
mones do change the membrane's response to vaso-
pressin. Alpha-adrenergic stimulation with norepi-
nephrine interferes with the ability of vasopressin to
enhance water permeability of the toad bladder [10],
while beta-adrenergic stimulation with isoprotere-
nol was found to enhance the response of the toad
bladder to vasopressin [11]. Moreover, in vitro stud-
ies of isoproterenol in medullary tissue slices of the
dog showed that beta stimulation increased cyclic
adenosine monophosphate (AMP) production [12].
Since cyclic AMP is assumed to be the intracellular
mediator of the action of ADH [13], these studies
suggestesd that beta-adrenergic stimulation might en-
hance tubular permeability to water by enhancing
cyclic AMP production. It is noteworthy, however,
that rat medullary tissue slices showed no increases in
cyclic AMP production when treated with isoprotere-
nol [121. Yet the rat, like the dog, shows an antidiu-
retic response to isoproterenol when this beta stimu-
lator is given sytemically [5].
A number of in vivo studies have also addressed the
question of how alpha and beta stimulators affect
renal water excretion. Fisher [6] reported that water-
loaded human subjects receiving a low dose of ex-
ogenous vasopressin had a diuretic response to the
i.v. administration of norepinephrine. This study,
however, did not exclude the possibility that the
pressor effect of norepinephrine counteracted the ef-
fect of vasopressin. Nor was the study designed in a
way to exclude the possibility that norepinephrine
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suppressed endogenous ADH release. Studies per-
formed in the rat by Liberman, Klein and Kleeman
[5], however, lent further support to the possibility
that the catecholamines exerted their effect on renal
water excretion intrarenally rather than by altering
ADH release. Their studies showed that isoprotere-
no! caused a modest antidiuresis in rats with con-
genital diabetes insipidus. Moreover, isoproterenol
caused no detectable rise in bioassayable vasopressin
in the jugular venous blood of the dog [14]. Neither
systemic nor renal hemodynamics were measured,
however, in these experiments. However, isoprotere-
not infusions in man [15] gave conflicting bioassay-
able vasopressin results when compared to those
obtained in the dog [14]. Recently, Berl, Harbottle
and Schrier [9] have shown that norepinephrine ad-
ministered i.v. to normal hydropenic man caused a
diuresis. This diuresis, however, did not occur in
patients with diabetes insipidus who were receiv-
ing a low dose of vasopressin. Conversely, nor-
mal subjects undergoing a water diuresis demon-
strated an antidiuresis in response to the i.v. ad-
ministration of isoproterenol, but patients with un-
treated pituitary diabetes insipidus did not. The sys-
temic and renal hemodynamic responses to the i.v.
infusions of catecholamines were similar in nor-
mal subjects and patients with diabetes insipidus.
The findings of this study [9] support the concept
that the major effect of i.v. administered catechol-
amines on water excretion is exerted through changes
in vasopressin release.
Therefore, while some of the above studies pro-
vided suggestive evidence that catecholamines ex-
erted an intrarenal effect on water excretion, the pos-
sibility was not excluded that changes in perfusion
pressure or endogenous ADH or both were respon-
sible for the effects of the catecholamines on water
handling by the kidney. A series of experiments per-
formed in our laboratory showed that systemic in-
fusions of isoproterenol increased urinary osmolality
and decreased free water clearance in the anesthetized
dog even when renal perfusion pressure was kept
constant. The opposite effects on renal water excre-
tion were seen during i.v. infusions of norepinephrine
[4]. However, direct intrarenal infusion of isoprotere-
no! at a dose which had no effect on systemic he-
modynamics caused a slight diuresis, rather than an
antidiuresis [8]. Conversely, intrarenal infusions of
norepinephrine caused an antidiuresis [4]. These ef-
fects, therefore, were the opposite to those seen with
systemic infusions of the catecholamines and sugges-
ted that the effects of such systemic infusions on renal
water excretion were the result of extrarenal actions
of the catecholamines. Further studies in the dog
suggested that this extrarenal action might involve an
alteration of endogenous vasopressin release. This
evidence largely rested on the observation that when
the catecholamines were given to acutely hypophy-
sectomized dogs, no significant change in renal water
excretion occurred. Acute hypophysectomy in the
dog results in virtual elimination of circulating en-
dogenous ADH (unpublished observation) and
causes acute diabetes insipidus. Hence, it seems ap-
propriate to conclude that the lack of effect of the
catecholamines on water excretion in these dogs was
likely to be the result of their lack of endogenous
ADH.
The further question arose as to how the cate-
cholamines influenced ADH release. Infusions of ei-
ther isoproterenol or norepinephrine were given di-
rectly into the carotid arteries at doses which were
estimated to produce blood concentrations com-
parable to those achieved during the systemic in-
fusions of the previous studies [16, 17]. These in-
tracarotid infusions caused no change in systemic
hemodynamics and, more importantly, no changes in
renal water excretion [16, 17]. Therefore, these stud-
ies provided no evidence that the catecholamines al-
tered ADH release by direct actions on the hypo-
thalamic-neurohypophyseal axis. This raised the
possibility that the catecholamines affected ADH re-
lease indirectly by way of their effect on the systemic
circulation. To test this possibility, carotid barore-
ceptors were denervated in dogs with an intact hy-
pothalamic-neurohypophyseal system. When these
animals were given isoproterenol i.v. while under-
going a water diuresis, they showed no antidiuretic
response to beta-adrenergic stimulation [17]. Also,
norepinephrine given i.v. to dehydrated dogs with
denervated baroreceptors exerted no diuretic effect
[16]. Taken together, this series of experiments sup-
ported the concept that vasoactive agents, such as
the catecholamines, play important roles in regulat-
ing ADH release and that they do so by way of their
effect on vascular baroreceptors. Subsequent studies
have shown that many other vasoactive substances—
including angiotensin II [18], prostaglandin E1 [19)
and nicotine [20]—also exert effects on ADH release
by way of arterial baroreceptor and the afferent
neural pathways to the brain.
There obviously remains the possibility that brain
catecholamines might mediate ADH release directly,
but that this effect was not detectable during in-
tracarotid infusions of the catecholamines. Never-
theless, our studies emphasize the importance of the
effects of catecholamines on the systemic circulation
in influencing ADH release through baroreceptor re-
flexes.
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Thyroid hormone
A role for thyroid hormone in the regulation of
renal water excretion has been implicated by the re-
peated observation that human subjects with hypo-
thyroidism have an impaired ability to excrete a wa-
ter load. However, the mechanisms by which thyroid
hormone facilitates water excretion remain unclear.
One possibility is that the hormone enhances delivery
of tubular fluid to distal diluting sites. This mecha-
nism is supported by the observation that free water
clearance appears to be impaired more than minimal
urine osmolality in hypothyroid human subjects as
well as by the observations of Emmanouel, Lind-
heimer and Katz in the hypothyroid rat [22]. A de-
crease in distal delivery could be the result of the
decrease in glomerular filtration rate which com-
monly accompanies hypothyroidism [23]. However,
these decreases in glomerular filtration rate are usu-
ally very modest and would not be expected to ac-
count for any major impairment in water excretion.
An increase in proximal tubular fluid reabsorption
might also account for a decrease in fluid delivery to
the distal tubule. However, the micropuncture studies
of Michael et al [24] demonstrated a decrease, rather
than an increase, in sodium and water reabsorption
in the proximal tubule of the hypothyroid rat. There-
fore, these direct measurements tend to refute the role
of proximal reabsorption in causing a decrease in
distal tubular fluid delivery. The report of Michael et
al [251 suggests, however, that in the hypothyroid rat
a diluting defect may exist in the distal nephron. The
possibility that tubular sodium reabsorption may be
influenced directly by thyroid hormone has been sup-
ported by the work of Ismail-Beigi and Edelman [26],
who reported that triiodothyronine decreases in-
tracellular sodium concentration by enhancing the
action of sodium-potassium-adenosine triphospha-
tase (Na-K ATPase) on sodium transport.
Since the evidence that thyroid hormone alters dis-
tal tubular fluid delivery is conflicting and in-
conclusive, alternative explanations of the impaired
water excretion in hypothyroidism have been consid-
ered. Chief among these is the possibility that thyroid
hormone influences the secretion of ADH or alters
renal tubular sensitivity to this hormone. To date,
there appears to have been no systematic effort to
evaluate the effect of thyroid hormone on tubular
sensitivity to ADH. Even if hypothyroidism en-
hanced tubular responsiveness to ADH, one would
not expect any marked impairment of water excretion
to result if the rate of ADH secretion were reduced
through appropriate physiologic feedback mecha-
nisms. Much of the same argument can be advanced
against impaired metabolic inactivation of ADH in
hypothyroidism as a cause for impaired water excre-
tion. If the half-life of the hormone were prolonged
or if its affect on the renal tubule were enhanced by
hypothyroidism, then a resulting increase in water
retention should only be transient. It should be lim-
ited by physiologic feedback systems decreasing
ADH secretion, either through osmolar or nonos-
molar mechanisms.
A more attractive, but equally unproven, mecha-
nism linking thyroid hormone to water excretion in-
volves an effect of the hormone on ADH secretion. If
thyroid hormone, either directly or indirectly, sup-
pressed ADH secretion, then hypothyroidism might
be associated with enhanced ADH secretion. This
would account for the impaired water excretion of
hypothyroidism and the associated hyponatremia.
The observation that ethanol increases water excre-
tion in patients with hypothyroidism [27] supports
this mechanism. However, this finding was not con-
firmed in another study [28]. As will be noted else-
where in this symposium, the degree of severity of
water retention and the mechanisms responsible for it
might well depend upon the severity of the hypothy-
roidism. Obviously, the role of ADH in hypothy-
roidism will only be conclusively resolved by accurate
measurements of plasma ADH concentrations.
Adrenal cortical hormones
Adrenal insufficiency in both man and experimen-
tal animals has been consistently associated with an
impairment in water excretion [28, 29]. The mecha-
nisms responsible for this phenomenon, however, are
unclear. Part of the confusion about mechanisms has
centered about the relative roles of the glucocorticoid
versus the mineralocorticoids in influencing water ex-
cretion.
Glucocorgicoids. Glucocorticoid replacement alone,
without simultaneous administration of miner-
alocorticoids, has been shown to correct impaired
water excretion in adrenal insufficiency in both phar-
macological [21, 31] and physiological [32] doses.
Kleeman, Czaczkes and Cutler [29] have concluded
that the glucocorticoids promote maximal water im-
permeability of the collecting duct and through this
action ensure maximal renal water excretion. This
conclusion was not supported by the work of Handler,
Preston and Orloff using the toad bladder [33]. In
contrast, however, Dingman and Despointes [34] ob-
served, on the basis of bioassay measurements of
plasma ADH, that inappropriately high plasma con-
centrations of ADH persist in Addisonian patients
receiving a water load. They concluded that glucocor-
ticoid deficiency resulted in excessive ADH secretion
and that this abnormality accounted for the impaired
Hormonal control of renal water excretion 41
water excretion. A recent observation by Boykin et a!
[35] supports this conclusion. This study showed that
chronically adrenalectomized conscious dogs receiv-
ing mineralocorticoid, but not glucocorticoid re-
placement, maintained high plasma concentrations of
ADH during water loading. These high ADH levels,
measured by radioimmunoassay [36], were associated
with a marked impairment of urine dilution and free
water clearance. The reason for the persistently high
plasma ADH concentrations during water loading
were not clearly identified. However, there was a
suggestion that it may have been mediated by the
systemic hemodynamic effects resulting from gluco-
corticoid deficiency. These effects included a tach-
ycardia and decreased cardiac stroke volume, al-
though the cardiac output and arterial blood pres-
sures were not significantly different from control
values. Thus, the possibility arises that systemic he-
modynamic stimuli, mediated through baroreceptor
mechanisms, might promote ADH release in gluco-
corticoid deficient states. If this proposal is true, then
the hemodynamic stimuli must hold precedence over
osmolar stimuli under the conditions of these experi-
ments.
None of these studies reported to date exclude the
possibility that glucocorticoids suppress ADH release
by a direct action on the hypothalamic-neurohy-
pophyseal axis. A direct effect of the glucocorticoids
on the hypothalamus might blunt neurogenic stimuli
or enhance osmolar stimuli for ADH release. If this
were so, then in glucocorticoid insufficiency barore-
ceptor stimuli would be unopposed by the glucocorti-
coids arid would cause greater than normal ADH
release. Clearly, further studies are required to estab-
lish whether such a relationship exists between the
glucocorticoids and baroreceptor-mediated stimuli of
ADH release.
It also is apparent that the glucocorticoids are ca-
pable of enhancing renal water excretion by increas-
ing glomerular filtration rate [37]. This effect is most
apparent when the steroids are given in large pharma-
cological dosages, but might also have a physiologic
counterpart.
Mineralocorticoids. The role of the mineralo-
corticoids in mediating the impaired water excre-
tion of adrenal insufficiency has also been examined
in several studies. The studies of Ufferman and
Schrier [38] in adrenalectomized conscious dogs in-
dicated that mineralocorticoids do enhance renal wa-
ter excretion when given over a period of several
days. This effect was associated with correction of
hyponatremia and a positive sodium balance. These
studies also demonstrated that comparable improve-
ment in water excretion could be achieved in the
absence of mineralocorticoid replacements through
fluid and electrolyte administration sufficient to
maintain normal extracellular fluid volume. The re-
ports of Gill, Gann and Bartter [39] and Share and
Travis [30] also showed that water excretion was
improved by saline administration in adrenal in-
sufficiency in man and dogs, respectively. Moreover,
the latter workers demonstrated that the improve-
ment was associated with a decrease in bioassayable
plasma vasopressin concentrations [30]. Recent stud-
ies by Boykin et al [40] have shown that impaired
water excretion in mineralocorticoid-deficient, con-
scious dogs also impairs water excretion and that the
impairment was associated with incomplete suppres-
sion of immunoassayable ADH. Therefore, miner-
alocorticoids would appear to influence ADH secre-
tion indirectly by maintaining extracellular fluid
volume and thus avoiding the nonosmotic release of
vasopressin associated with volume depletion. It
should also be noted that glucocorticoids and miner-
alocorticoids seem capable of improving renal dilut-
ing capacity independently of any effect on vasopres-
sin release. This was demonstrated in the report of
Green, Harrington and Valtin [41] in which adrenal-
ectomized rats with diabetes insipidus were shown to
normalize water excretion only when both glucocorti-
coids and mineralocorticoids were given.
Renin-angiotensin system
Since the renin-angiotensin system is one of the
mechanisms regulating aldosterone secretion, it fol-
lows that the system might exert an effect on water
excretion through the mineralocorticoid actions of
aldosterone. However, the possibility has also been
raised that angiotensin II is a direct stimulator of
vasopressin release [42]. Since vasopressin is capable
of suppressing renin release [43], the possible exis-
tence of a negative feedback mechanism between
vasopressin and the renin-angiotensin system has
been considered. The data supporting a role for ang-
iotensin II as a trophic hormone for vasopressin,
however, are conflicting. Mouw et al [44] have shown
that either intracarotid or i.v. infusions of angioten-
sin H resulted in an increase in plasma vasopressin
concentrations. Furthermore, Keil, Summy-Long
and Severs [45] have shown that infusions of angio-
tensin II into the lateral cerebral ventricle of the rat
cause an increase in plasma ADH concentrations.
On the other hand, Cadnapaphornchai et a! [18]
showed that i.v. infusions of angiotensin II in dogs
caused a diuresis, an effect opposite to what would
have been expected had the angiotensin II stimulated
ADH release. In acutely hypophysectomized dogs
receiving a constant infusion of vasopressin, angio-
tensin II no longer caused a diuresis. Moreover, when
angiotensin II was given into a carotid artery in sub-
42 McDonald e a!
pressor doses, there was no change in renal water
excretion. Finally, this study also showed that a com-
petitive inhibitor of angiotensin Il—sar', gly8 angio-
tensin Il—had no effect on water excretion in the
hydropenic dog. Therefore, this study failed to sup-
port the concept that angiotensin H stimulates vaso-
pressin release. Rather, it suggested that angiotensin
H shared with other pressor substances, such as nor-
epinephrine [4, 17], the ability to suppress ADH re-
lease through extracerebral mechanisms.
Other studies have also failed to confirm that ang-
iotensin II stimulates ADH release. Bioassayable
vasopressin failed to rise during systemic angiotensin
II infusions [47] or in situations such as modest hem-
orrhage [48] or fluid ultrafiltration during hemo-
dialysis [49] when endogenous renin and angiotensin
were elevated.
Studies performed on isolated posterior pituitaries
have shown that angiotensin II is capable of directly
stimulating cyclic AM P production and ADH release
from this tissue [50]. Therefore, there would appear
to be receptors in the neurohypophysis capable of
responding to angiotensin II. However, the phys-
iological significance of these results must be ques-
tioned in view of the difficulty of showing vasopres-
sin-releasing activity of angiotensin II in vivo.
Prostaglandins
An unresolved controversy exists about whether
the prostaglandins function as circulating hormones
[51-531. There is little doubt, however, that these fatty
acids act locally at their sites of synthesis in many
tissues to exert a variety of physiologically important
effects. One of the richest sites of prostaglandin pro-
duction is the renal medulla [54]. Prostaglandin E2
(POE2) is the most abundant prostaglandin produced
at this site and appears to be synthesized both in
interstitial cells and collecting duct cells [55]. Consid-
erable data have accumulated to suggest that POE
may have major effects on epithelial membrane per-
meability to water. Of particular interest has been the
observation that PGE interferes with the ability of
vasopressin to enhance water permeability of such
tissues as the rabbit collecting duct [56] and anuran
membranes [57, 581. In vitro, this effect of PGE ap-
pears to be mediated through an inhibition of the
ability of ADH to stimulate production of its in-
tracellular mediator, cyclic AMP [59]. Recent studies
by Anderson et al [60], Lum et al [61] and Berl et al
[62] have indicated that the renomedullary pros-
taglandins also modulate the action of vasopressin in
vivo. These workers have shown in the dog [60] and
either the anesthetized [61] or conscious rat [62] that
antiinflammatory drugs (indomethacin, meclofena-
mate, aspirin) which inhibit prostaglandin synthesis
enhance both the hydroosmotic [60, 62] and the renal
medullary cyclic AMP responses to vasopressin [61].
These studies support the hypothesis that medullary
prostaglandins influence renal sensitivity to ADH.
It should be noted that POE, alone, at relatively
high concentrations stimulates, rather than sup-
presses, cyclic AM P production in the isolated col-
lecting duct of the rabbit [56], as well as in the toad
bladder [57] and the inner medulla of the rat [59].
This raises the possibility that renal prostaglandins
might influence water excretion by a direct tubular
action independent of ADH.
Evidence has also accumulated showing that en-
dogenous renal prostaglandins may affect renal he-
modynamics [63]. Prostaglandin depletion with in-
domethacin has been shown to cause a redistribution
of renal blood flow away from the inner cortex and,
presumably, away from the medulla as well [64]. This
could result in a decrease in removal of medullary
interstitial solute and an enhancement of the me-
dullary and papillary hyperosmolality generated by
the countercurrent multiplier mechanism. This he-
modynamic mechanism, therefore, could also en-
hance the hydroosmotic responsiveness of the kidney
to ADH. However, whether such an intrarenal he-
modynamic role of prostaglandins is of physiologic
significance remains speculative. Cadnapaphornchai
et al [20] have also shown that POE1 is capable of
influencing water excretion through a systemic effect.
This action appeared to arise from the influence of
POE1 on arterial pressure, with consequent stimu-
lation of ADH release through nonosmolar barore-
ceptor pathways.
A recent preliminary report by Yamamoto, Share
and Shade [65] also suggests another means by which
prostaglandins might influence water excretion.
These workers reported that ventriculo-cisternal per-
fusion of POE2 in the anesthetized dog induced an
increase in circulating ADH concentrations. Other
reports have also demonstrated that intracarotid in-
fusion of POE2 may result in an increase in urinary
osmolality in rats independently of any changes in
arterial blood pressure [66]. These observations raise
the possibility that brain prostaglandins might stimu-
late ADH release. However, the available data are
inadequate to establish whether the ADH-releasing
activity of PGE2 is simply a pharmacological effect or
whether endogenous prostaglandins might also me-
diate ADH release.
Prolactin
Prolactin, the anterior pituitary hormone involved
in the control of lactation, appears to be an os-
moregulating hormone in fishes [67] and birds [68].
Studies in the perfused kidney of the cat [69], the
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unanesthetized rat [70], the rat with congenital diabe-
tes insipidus [711, as well as in man [72] demonstrated
that the administration of prolactin was associated
with a decrease in cation or water excretion or both.
Thus, these findings suggested a role for prolactin in
the control of fluid balance in mammals. Most of
these studies, however, have employed pharma-
cologic amounts of the hormone and a possible con-
tamination of the preparations with either growth
hormone or vasopressin itself has been suspected.
Recent studies in which endogenous prolactin con-
centrations were increased in normal subjects by the
i.v. administration of thyroid releasing hormone
(TRH), however, have failed to show a significant
effect on renal water excretion [73]. Furthermore,
studies suggesting that the secretion of prolactin is
under osmoregulatory control in man [74] have not
been substantiated by more recent investigations [73,
75]. It appears, therefore, that while prolactin may
play a role in the osmoregulation of some lower
species, it probably has no such physiological func-
tion in man.
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